Thioredoxin, a novel agent for mitigating radiation-induced hematopoietic injury
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
September 9, 2022
End Date
August 31, 2024
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
September 9, 2022
End Date
August 31, 2024